Nascent Pharma Holdings, Inc.
NASC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$628.18K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $628,183.00 |
|---|---|
| Enterprise Value | $9.63 Million |
| Earnings per Share | $-0.06 |
| Beta | 0.61 |
| Outstanding Shares | 65,435,733 |
Return
| Return on Equity | 124.11% |
|---|---|
| Return on Assets | -654.43% |
| Return on Invested Capital | 98.04% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | 0.74 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 9.82 |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | -0.92 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-1.50
Consensus analyst estimateRevenue Estimate
$172,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-1.50
Consensus analyst estimateRevenue Estimate
$172,000
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Can B Corp
12 employees
CEO: Marco Alfonsi
Nascent Pharma Holdings, Inc. is primarily engaged in both protecting and bringing to market intellectual property pertaining to cannabis. Beyond this, the company also manufactures superfood beverage mixes, which are marketed under its ...